日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy

对接受 5-氟尿嘧啶/卡培他滨联合放化疗的二氢嘧啶脱氢酶活性降低患者的管理

Hoffmann, E; Toepell, A; Peter, A; Böke, S; De-Colle, C; Steinle, M; Niyazi, M; Gani, C

An Activity Tracker-Guided Physical Activity Program for Patients Undergoing Radiotherapy: Protocol for a Prospective Phase III Trial (OnkoFit I and II Trials)

针对接受放射治疗的患者的活动追踪器指导下的身体活动计划:前瞻性 III 期试验方案(OnkoFit I 和 II 期试验)

Hauth, Franziska; Gehler, Barbara; Nieß, Andreas Michael; Fischer, Katharina; Toepell, Andreas; Heinrich, Vanessa; Roesel, Inka; Peter, Andreas; Renovanz, Mirjam; Hartkopf, Andreas; Stengel, Andreas; Zips, Daniel; Gani, Cihan

The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis

产前教育计划预防先天性弓形虫病的有效性

Carter, A O; Gelmon, S B; Wells, G A; Toepell, A P